The risk of breast and ovarian cancer among women with mutations such as BRCA1 and BRCA2 mutations can be mitigated by operations to remove the organs at greatest risk. Data are presented to assist in deciding what operation should be performed and when it should occur.
No takes yet. Share an insight, caveat, or question.
Hartmann et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: